Company Overview and News
THE Light Rail Manila Corp. (LRMC) is seeking to raise fares at the Light Trail Transit Line 1 (LRT-1) by P5 to P7 in August.
The group led by businessman Manuel V. Pangilinan is rethinking options on the 800-megawatt natural gas-fired combined cycle facility in Jurong, Singapore, following a power supply glut that has affected the entire power-generation space in the city-state.
METRO PACIFIC Investments Corp. Chief Finance Officer David J. Nicol said the group is assessing options for a liquefied natural gas (LNG) power plant owned by its unit Manila Electric Co. (Meralco) and parent First Pacific Ltd. in Singapore, where a surplus in power capacity has put a pressure on prices.
THE power units of Metro Pacific Investments Corp. (MPIC) will be expanding their capacity by around 1,600 megawatts (MW) until 2022, with plans to invest around P30 billion during the period.
METRO PACIFIC Investments Corp. (MPIC) grew first-quarter earnings by 16% on the back of better-than-expected volume growth in its business units, as the infrastructure conglomerate remains hopeful of reaching an acceptable agreement with the government on its long-pending tariff issues.
METRO PACIFIC Investments Corp. (MPIC) has submitted a bid for a tollway project in Malaysia, eyeing to close an agreement for the venture within the year.
INTEGRATED sugar and ethanol producing firm Roxas Holdings, Inc. (RHI) anticipates lower sugar production this year.
MPCALA HOLDINGS, Inc. has tapped Leighton Asia to build the Cavite segment of the Cavite-Laguna Expressway (CALAX).
PXP ENERGY Corp. posted a bigger consolidated net loss of P39.1 million in 2017, weighed down by foreign exchange losses and higher tax provision, the company told the stock exchange on Wednesday.
NLEX CORP. yesterday formally opened the Subic-Clark-Tarlac Expressway (SCTEx) Mabiga interchange and the North Luzon Expressway (NLEx) Sta. Ines-Magalang exit.
LIGHT RAIL Manila Corp. (LRMC) has signed a P450-million agreement with Voith Digital Solutions Austria GmBH and Co KG for the rehabilitation and upgrade of Light Rail Transit-1 (LRT-1) generation-2 trains.
THE METRO PACIFIC group is expected to secure original proponent status (OPS) for the Cavite-Tagaytay-Batangas Expressway (CTBEx) this month.
ROXAS HOLDINGS, Inc. (RHI) narrowed its net loss by 2% during the first quarter of crop year 2018, as revenues surged on higher volume of sugar sold.
THE LAGUNA Boulevard to Mamplasan section of the Cavite-Laguna Expressway (CALAEx) can be opened by December, according to Department of Public Works and Highways (DPWH) Secretary Mark A. Villar.
LIGHT RAIL Manila Corp. (LRMC) may start by midyear the construction of the Light Rail Transit (LRT)-1 extension to Cavite.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...